Showing 11,641 - 11,660 results of 54,458 for search '(( 5 ((we decrease) OR (teer decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 1.11s Refine Results
  1. 11641

    Image 5_Cellular interactions and Ion channel signatures in atrial fibrillation remodeling: insights from single-cell analysis and machine learning.tif by Bin He (75597)

    Published 2025
    “…In the AF group, the proportions of EF, APF, and LBCs were increased, whereas the proportion of EC was decreased; by contrast, the SR group displayed a higher proportion of EC. …”
  2. 11642
  3. 11643

    Prenatal Air Pollution Exposure and Early Cardiovascular Phenotypes in Young Adults by Carrie V. Breton (74382)

    Published 2016
    “…For example, a 2 SD increase in prenatal PM<sub>2.5</sub> was associated with CAS indices, including a 5% increase (β = 1.05, 95% CI 1.00–1.10) in carotid stiffness index beta, a 5% increase (β = 1.05, 95% CI 1.01–1.10) in Young’s elastic modulus and a 5% decrease (β = 0.95, 95% CI 0.91–0.99) in distensibility. …”
  4. 11644

    Image_5_Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis – 2 Years Follow up Experience From India.jpg by Vijay Kumar (377076)

    Published 2022
    “…The Sievers type 1 included 78.5%, type 0 were 21.4% of the cases and there was no case of type 2 in the study. …”
  5. 11645
  6. 11646
  7. 11647

    CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants by Kalpana Dommaraju (650755)

    Published 2014
    “…Comparisons between the vaccine and placebo arm did not reveal robust evidence for a T cell driven sieve effect, although some differences were noted in Env-V2 (0.022≤p-value≤0.231). The paucity of CD8 T cell responses identified following RV144 vaccination, with no evidence for V2 specificity, considered together both with the association of decreased infection risk in RV 144 participants with V-specific antibody responses and a V2 sieve effect, lead us to hypothesize that this sieve effect was not T cell specific. …”
  8. 11648
  9. 11649

    Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model by Natália de Souza Xavier Costa (4474648)

    Published 2017
    “…</p><p>Results</p><p>The LPS 24h group showed increased pro-inflammatory cytokine levels, intense cell influx, increased total septal volume, septal thickening and decreased surface density of the alveolar septa. The LPS 5w group showed persistent lung inflammation, septal thickening, increased total lung volume, accentuated collagen deposition, especially of collagen type I, and decreased MMP-2 protein expression.…”
  10. 11650

    Data_Sheet_2_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  11. 11651

    Data_Sheet_1_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  12. 11652

    Data_Sheet_3_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  13. 11653

    Data_Sheet_4_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  14. 11654
  15. 11655

    Schematic overview of molecular processes altered during disease progression in the SN of PD, identified using transcriptome analysis. by Anke A. Dijkstra (756877)

    Published 2015
    “…In addition, we observed down regulation of mRNA levels of the upstream regulators in mTOR pathway. …”
  16. 11656
  17. 11657
  18. 11658

    Data_Sheet_1_Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses.PDF by Lubna Pinky (2794879)

    Published 2022
    “…We find that population-level effect of viral block is a decrease in the number of people infected with the suppressed virus. …”
  19. 11659

    Image_1_RETRACTED: The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.PDF by Chunqing Yang (6271727)

    Published 2024
    “…Besides, in this study we found that MCM3AP-AS1 knockdown decreased KLF5 and AGGF1 expression by upregulating miR-211. …”
  20. 11660

    Image_2_The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.PDF by Chunqing Yang (6271727)

    Published 2023
    “…Besides, in this study we found that MCM3AP-AS1 knockdown decreased KLF5 and AGGF1 expression by upregulating miR-211. …”